Nabu Therapeutics

A wholly-owned affiliate of Babylon Bio.

Sacha Schermerhorn: CEO
John Macor, PhD: CSO
Dario Doller, PhD: VP of Chemistry
Andrew Ambrose, PhD: Scientist